NuVasive, Inc. (NUVA): Price and Financial Metrics


NuVasive, Inc. (NUVA): $50.26

1.10 (+2.24%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

NUVA POWR Grades


  • NUVA scores best on the Value dimension, with a Value rank ahead of 88.21% of US stocks.
  • The strongest trend for NUVA is in Growth, which has been heading down over the past 179 days.
  • NUVA's current lowest rank is in the Sentiment metric (where it is better than 3.17% of US stocks).

NUVA Stock Summary

  • With a year-over-year growth in debt of -34.26%, Nuvasive Inc's debt growth rate surpasses only 11.86% of about US stocks.
  • In terms of twelve month growth in earnings before interest and taxes, Nuvasive Inc is reporting a growth rate of -262.86%; that's higher than merely 7.37% of US stocks.
  • Nuvasive Inc's shareholder yield -- a measure of how much capital is returned to stockholders via dividends and buybacks -- is 22.36%, greater than the shareholder yield of 92.2% of stocks in our set.
  • Stocks that are quantitatively similar to NUVA, based on their financial statements, market capitalization, and price volatility, are MTRN, NLS, BRC, ISDR, and ASTE.
  • Visit NUVA's SEC page to see the company's official filings. To visit the company's web site, go to www.nuvasive.com.

NUVA Valuation Summary

  • In comparison to the median Healthcare stock, NUVA's price/sales ratio is 75.33% lower, now standing at 2.8.
  • NUVA's price/earnings ratio has moved up 1755.3 over the prior 211 months.
  • NUVA's price/sales ratio has moved down 7.5 over the prior 211 months.

Below are key valuation metrics over time for NUVA.

Stock Date P/S P/B P/E EV/EBIT
NUVA 2021-08-31 2.8 3.8 1732.5 64.8
NUVA 2021-08-30 2.7 3.7 1656.7 62.5
NUVA 2021-08-27 2.7 3.7 1671.8 63.0
NUVA 2021-08-26 2.7 3.6 1651.7 62.4
NUVA 2021-08-25 2.6 3.6 1643.6 62.2
NUVA 2021-08-24 2.7 3.7 1673.4 63.0

NUVA Growth Metrics

    The 2 year net income to common stockholders growth rate now stands at 41.85%.
  • Its 3 year revenue growth rate is now at 33.84%.
  • Its 4 year cash and equivalents growth rate is now at 85.09%.
NUVA's revenue has moved up $305,154,000 over the prior 70 months.

The table below shows NUVA's growth in key financial areas (numbers in millions of US dollars).

Date Revenue Operating Cash Flow Net Income to Common Stock
2021-12-31 1,138.988 182.174 -64.086
2021-09-30 1,128.72 217.483 -25.658
2021-06-30 1,153.166 232.2 1.853
2021-03-31 1,061.95 212.325 -49.961
2020-12-31 1,050.582 185.911 -37.153
2020-09-30 1,069.129 187.903 -8.969

NUVA's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.
  • NUVA has a Quality Grade of C, ranking ahead of 59.67% of graded US stocks.
  • NUVA's asset turnover comes in at 0.477 -- ranking 99th of 186 Medical Equipment stocks.
  • DYNT, IRMD, and ELMD are the stocks whose asset turnover ratios are most correlated with NUVA.

The table below shows NUVA's key quality metrics over time.

Period Asset Turnover Gross Margin ROIC
2021-06-30 0.477 0.723 0.034
2021-03-31 0.418 0.697 0.001
2020-12-31 0.411 0.694 0.014
2020-09-30 0.454 0.700 0.027
2020-06-30 0.495 0.706 0.028
2020-03-31 0.595 0.731 0.088

NUVA Price Target

For more insight on analysts targets of NUVA, see our NUVA price target page. And for a list of of all stocks sorted by upside potential based on analyst target price, see our Top Price Target page.

Average Price Target $74.07 Average Broker Recommendation 1.75 (Moderate Buy)

NUVA Stock Price Chart Interactive Chart >

Price chart for NUVA

NUVA Price/Volume Stats

Current price $50.26 52-week high $68.72
Prev. close $49.16 52-week low $45.45
Day low $48.53 Volume 250,700
Day high $50.70 Avg. volume 565,032
50-day MA $52.82 Dividend yield N/A
200-day MA $54.10 Market Cap 2.62B

NuVasive, Inc. (NUVA) Company Bio


NuVasive develops and markets minimally-disruptive surgical products and procedurally-integrated solutions for the spine. Its products focus on applications for spine fusion surgery. The company was founded in 1997 and is based in San Diego, California.


NUVA Latest News Stream


Event/Time News Detail
Loading, please wait...

NUVA Latest Social Stream


Loading social stream, please wait...

View Full NUVA Social Stream

Latest NUVA News From Around the Web

Below are the latest news stories about Nuvasive Inc that investors may wish to consider to help them evaluate NUVA as an investment opportunity.

NuVasive (NUVA) Q4 Earnings Miss Estimates, Gross Margin Up

Continued strong international performance and introduction of products drove NuVasive's (NUVA) revenues in the fourth quarter of 2021.

Yahoo | February 24, 2022

NuVasive (NUVA) Q4 Earnings Lag Estimates

NuVasive (NUVA) delivered earnings and revenue surprises of -14.89% and 1.50%, respectively, for the quarter ended December 2021. Do the numbers hold clues to what lies ahead for the stock?

Yahoo | February 23, 2022

NuVasive Announces Fourth Quarter and Full Year 2021 Financial Results and 2022 Outlook

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, today announced financial results for the quarter and full year ended December 31, 2021.

Yahoo | February 23, 2022

NuVasive to Participate in 42nd Annual Cowen Healthcare Conference

NuVasive, Inc. (NASDAQ: NUVA), the leader in spine technology innovation, focused on transforming spine surgery with minimally disruptive, procedurally integrated solutions, announced today that Chief Executive Officer Chris Barry will virtually present at the 42nd Annual Cowen Healthcare Conference on Tuesday, March 8, 2022 at 8:10 a.m. PT / 11:10 a.m. ET.

Yahoo | February 22, 2022

Border to Coast Pensions Partnership Ltd Buys PayPal Holdings Inc, Big Lots Inc, Fiserv Inc, ...

Investment company Border to Coast Pensions Partnership Ltd (Current Portfolio) buys PayPal Holdings Inc, Big Lots Inc, Fiserv Inc, NOV Inc, Mastercard Inc, sells Peloton Interactive Inc, Alliance Data Systems Corp, Alibaba Group Holding, M&T Bank Corp, Canada Goose Holdings Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Border to Coast Pensions Partnership Ltd.

Yahoo | February 8, 2022

Read More 'NUVA' Stories Here

NUVA Price Returns

1-mo -6.11%
3-mo -8.28%
6-mo -7.13%
1-year -25.43%
3-year -11.33%
5-year -34.69%
YTD -4.23%
2021 -6.83%
2020 -27.17%
2019 56.05%
2018 -15.27%
2017 -13.17%

Continue Researching NUVA

Here are a few links from around the web to help you further your research on Nuvasive Inc's stock as an investment opportunity:

Nuvasive Inc (NUVA) Stock Price | Nasdaq
Nuvasive Inc (NUVA) Stock Quote, History and News - Yahoo Finance
Nuvasive Inc (NUVA) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!


Page generated in 0.6114 seconds.